Egypt’s Eva Pharma will supply India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement.

The company on Monday signed an agreement with the Indian embassy in Cairo, aimed at helping India combat a spike in infections which has overwhelmed the health system and held close to record daily highs on Monday.

Eva Pharma, a generic drugmaker established in 1997, said in June 2020 it had received a license from Gilead Sciences Inc to make remdesivir in Egypt and distribute it in 127 countries.

The drug targets moderate to severe cases of COVID-19 in intensive care who require oxygen.